Advanced search
Publication Cover
Future Oncology Volume 6, 2010 - Issue 9
Submit an article Journal homepage
234
Views
0
CrossRef citations to date
0
Altmetric
Review

Role of Cell Cycle Perturbations in the Combination Therapy of Chemotherapeutic Agents and Radiation

Bea Pauwels1 Laboratory of Cancer Research & Clinical Oncology, University of Antwerp, Universiteitsplein 1, 2610Wilrijk, Belgium. [email protected]Correspondence[email protected]
View further author information
,
An Wouters1 Laboratory of Cancer Research & Clinical Oncology, University of Antwerp, Universiteitsplein 1, 2610Wilrijk, Belgium. [email protected]View further author information
,
Marc Peeters1 Laboratory of Cancer Research & Clinical Oncology, University of Antwerp, Universiteitsplein 1, 2610Wilrijk, Belgium. [email protected]View further author information
,
Jan B Vermorken1 Laboratory of Cancer Research & Clinical Oncology, University of Antwerp, Universiteitsplein 1, 2610Wilrijk, Belgium. [email protected]View further author information
&
Filip Lardon1 Laboratory of Cancer Research & Clinical Oncology, University of Antwerp, Universiteitsplein 1, 2610Wilrijk, Belgium. [email protected]View further author information
Pages 1485-1496 | Published online: 04 Oct 2010

Bibliography

  • Gregoire V , BaumannM: Combined radiotherapy and chemotherapy. In: Basic Clinical Radiobiology (4th Edition).Van der KogelA, JoinerM (Eds). Hodder Arnold, UK, 246–258 (2009).
  • Steel GG , PeckhamMJ: Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.Int. J. Radiat. Oncol. Biol. Phys.5(1), 85–91 (1979).
  • Wouters BG , BeggA: Irradiation-induced damage and the DNA damage response. In: Basic Clinical Radiobiology (4th Edition). Van der Kogel A, JoinerM (Eds). Hodder Arnold, UK, 11–26 (2009)
  • Kastan MB , BartekJ: Cell-cycle checkpoints and cancer.Nature432(7015), 316–323 (2004).
  • DeGregori J , KowalikT, NevinsJR: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.Mol.Cell Biol.15(8), 4215–4224 (1995).
  • Agami R , BernardsR: Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.Cell102(1), 55–66 (2000).
  • Bartek J , LukasC, LukasJ: Checking on DNA damage in S phase.Nat. Rev. Mol. Cell Biol.5(10), 792–804 (2004).
  • Zhu Y , AlvarezC, DollRet al.: Intra-S-phase checkpoint activation by direct CDK2 inhibition.Mol. Cell Biol.24(14), 6268–6277 (2004).
  • Zips D : Tumour growth and response to radiation. In: Basic Clinical Radiobiology (4th Edition). Van der Kogel A, JoinerM (Eds). Hodder Arnold, London, 78–101 (2009)
  • Milas L , MasonKA, LiaoZ, AngKK: Chemoradiotherapy: emerging treatment improvement strategies.Head Neck.25(2), 152–167 (2003).
  • Shah MA , SchwartzGK: Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.Clin. Cancer Res.7(8), 2168–2181 (2001).
  • Terasima T , TolmachLJ: Variation in several responses of HeLa cells to X-irradiation during the division cycle.Biophys. J.3, 11–33 (1963).
  • McGinn CJ , ShewachDS, LawrenceTS: Radiosensitizing nucleosides.J. Natl Cancer Inst.88(17), 1193–1203 (1996).
  • Lawrence TS , ChangEY, HahnTM, HertelLW, ShewachS: Radiosensitization of pancreatic cancer cells by 2´,2´-difluoro-2´-deoxycytidine.Int. J. Radiat. Oncol. Biol. Phys.34(4), 867–872 (1996).
  • Shewach DS , LawrenceTS: Antimetabolite radiosensitizers.J. Clin. Oncol.25(26), 4043–4050 (2007).
  • Hwang HS , DavisTW, HoughtonJA, KinsellaTJ: Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization.Cancer Res.60(1), 92–100 (2000).
  • Kuo ML , KunugiKA, LindstromMJ, KinsellaTJ: The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.Cancer J. Sci. Am.3(3), 163–173 (1997).
  • Pauwels B , KorstA, LardonF, VermorkenJ: Combined modality therapy of gemcitabine and radiation.Oncologist10(1), 34–51 (2005).
  • Pauwels B , KorstAEC, PattynGGOet al.: Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro.Int. J. Radiat. Oncol. Biol. Phys.57(4), 1075–1083 (2003).
  • Morgan MA , ParselsLA, MaybaumJ, LawrenceTS: Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review.Clin. Cancer Res.14(21), 6744–6750 (2008).
  • Gregoire V , VanNT, StephensLCet al.: The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.Cancer Res.54(23), 6201–6209 (1994).
  • Kruczynski A , BarretJM, EtievantCet al.: Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.Biochem. Pharmacol.55(5), 635–648 (1998).
  • Kruczynski A , ColpaertF, TarayreJPet al.: Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.Cancer Chemother. Pharmacol.41(6), 437–447 (1998).
  • Edelstein MP , WolfeLA3rd, DuchDS: Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer.Semin. Oncol.23(2 Suppl. 5), 41–47 (1996).
  • Fukuoka K , AriokaH, IwamotoYet al.: Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells.Lung Cancer34(3), 451–460 (2001).
  • Simoens C , LardonF, PauwelsBet al.: Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.BMC Cancer8, 65–77 (2008).
  • Simoens C , VermorkenJB, KorstAEet al.: Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.Cancer Chemother. Pharmacol.58(2), 210–218 (2006).
  • Fukuoka K , AriokaH, IwamotoYet al.: Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells.Cancer Chemother. Pharmacol.49(5), 385–390 (2002).
  • Grau C , HoyerM, OvergaardJ: The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice.Int. J. Radiat. Oncol. Biol. Phys.30(5), 1141–1146 (1994).
  • Milas L , MilasMM, MasonKA: Combination of taxanes with radiation: preclinical studies.Semin Radiat Oncol.9(2 Suppl. 1), 12–26 (1999).
  • Hennequin C , GiocantiN, FavaudonV: S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells.Br. J. Cancer71(6), 1194–1198 (1995).
  • Hennequin C , GiocantiN, FavaudonV: Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.Cancer Res.56(8), 1842–1850 (1996).
  • Kim JS , AmorinoGP, PyoHet al.: The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells.Int. J. Radiat. Oncol. Biol. Phys.51(2), 525–534 (2001).
  • Kawato Y , FurutaT, AonumaMet al.: Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.Cancer Chemother. Pharmacol.28(3), 192–198 (1991).
  • Rich TA : Camptothecin radiation sensitization. In: Chemoradiation in Cancer Therapy (Volume ). Choy H (Ed.). Humana Press, NJ, USA, 93–105 (2003)
  • Boothman DA , WangM, ScheaRAet al.: Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells.Int. J. Radiat. Oncol. Biol. Phys.24(5), 939–948 (1992).
  • Chen AY , OkunieffP, PommierY, MitchellJB: Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives.Cancer Res.57(8), 1529–1536 (1997).
  • Minehan KJ , BonnerJA: The interaction of etoposide with radiation: variation in cytotoxicity with the sequence of treatment.Life Sci.53(15), L237–L242 (1993).
  • Giocanti N , HennequinC, BalossoJ, MahlerM, FavaudonV: DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide.Cancer Res.53(9), 2105–2111 (1993).
  • Shigematsu N , KawataT, IharaNet al.: Effect of combined treatment with radiation and low dose etoposide on cell survival.Anticancer Res.21(1A), 325–328 (2001).
  • Bonner JA , LawrenceTS: Doxorubicin decreases the repair of radiation-induced DNA damage.Int. J. Radiat. Biol.57(1), 55–64 (1990).
  • Byfield JE , LeeYC, TuL: Molecular interactions between adriamycin and x-ray damage in mammalian tumor cells.Int. J. Cancer19(2), 186–193 (1977).
  • Kimler BF , LeeperDB: The effect of adriamycin and radiation on G2 progression.Cancer Res.36(9 Pt 1), 3212–3216 (1976).
  • Supiot S , GouardS, CharrierJet al.: Mechanisms of cell sensitization to a radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines.Clin. Cancer Res.11(19 Pt 2), S7047–S7052 (2005).
  • Midander J , LittbrandB, EdsmyrF: Irradiation combined with bleomycin treatment of synchronized cells in culture under oxic and hypoxic conditions.Acta Radiol. Oncol.19(5), 395–400 (1980).
  • Bleehen NM , GilliesNE, TwentymanPR: The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture.Br. J. Radiol.47(558), 346–351 (1974).
  • Vanuytsel L , FengY, LanduytW, LeerJW, van der SchuerenE: The combined effect of bleomycin and irradiation on mouse lip mucosa. 2. Influence on the accumulation and repair of sublethal damage during fractionated irradiation.Radiother. Oncol.6(4), 267–273 (1986).
  • Baumann M , KrauseM, DikomeyEet al.: EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.Radiother. Oncol.83(3), 238–248 (2007).
  • Giovannetti E , MeyV, NannizziSet al.: Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.Mol. Pharmacol.68(1), 110–118 (2005).
  • Bischof M , WeberKJ, BlatterJ, WannenmacherM, LatzD: Interaction of pemetrexed disodium (Alimta, multitargeted antifolate) and irradiation in vitro.Int. J. Radiat. Oncol. Biol. Phys.52(5), 1381–1388 (2002).
  • Bischof M , HuberP, StoffregenC, WannenmacherM, WeberKJ: Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases.Int. J. Radiat. Oncol. Biol. Phys.57(1), 289–292 (2003).
  • Chen YC , PandyaK, KengPCet al.: Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines.Clin. Cancer Res.9(3), 969–975 (2003).
  • Kawabe T : G2 checkpoint abrogators as anticancer drugs.Mol. Cancer Ther.3(4), 513–519 (2004).
  • Tenzer A , PruschyM: Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators.Curr. Med. Chem. Anticancer Agents3(1), 35–46 (2003).
  • Powell SN , DeFrankJS, ConnellPet al.: Differential sensitivity of p53- and p53+ cells to caffeine-induced radiosensitization and override of G2 delay.Cancer Res.55(8), 1643–1648 (1995).
  • Bracey TS , WilliamsAC, ParaskevaC: Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.Clin. Cancer Res.3(8), 1371–1381 (1997).
  • Bunch RT , EastmanA: Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.Clin. Cancer Res.2(5), 791–797 (1996).
  • Playle LC , HicksDJ, QualtroughD, ParaskevaC: Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines.Br. J. Cancer87(3), 352–358 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.